Wentzville, MO, United States of America

Derrick L Ruble

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Transtech Pharma, Inc.. Active years: 2015.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Derrick L Ruble: Innovator in RAGE Fusion Protein Glycosylation

Introduction

Derrick L Ruble is a notable inventor based in Wentzville, MO (US). He has made significant contributions to the field of biotechnology, particularly in the area of protein glycosylation. His innovative work has led to the development of methods that enhance the understanding and application of RAGE fusion proteins.

Latest Patents

Derrick holds a patent for "Control of RAGE fusion protein glycosylation and RAGE fusion protein compositions." This invention relates to methods for controlling the glycosylation of a RAGE fusion protein. It also encompasses compositions that include a RAGE fusion protein, where at least 0.5% of the protein is aglycosylated, and no more than 53.2% of the protein is aglycosylated. This patent highlights his expertise in manipulating protein structures for potential therapeutic applications.

Career Highlights

Derrick is currently associated with Transtech Pharma, Inc., where he continues to advance his research in protein glycosylation. His work at Transtech Pharma has positioned him as a key player in the biotechnology sector, contributing to innovative solutions in drug development and protein engineering.

Collaborations

Derrick collaborates with talented professionals in his field, including Susanna Roe and Rodney G Combs. These partnerships enhance the research environment and foster innovation within the company.

Conclusion

Derrick L Ruble's contributions to the field of biotechnology, particularly through his patent on RAGE fusion protein glycosylation, demonstrate his commitment to advancing scientific knowledge and applications. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…